These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36535979)

  • 21. Drug-eluting beads loaded with antiangiogenic agents for chemoembolization: in vitro sunitinib loading and release and in vivo pharmacokinetics in an animal model.
    Fuchs K; Bize PE; Dormond O; Denys A; Doelker E; Borchard G; Jordan O
    J Vasc Interv Radiol; 2014 Mar; 25(3):379-87, 387.e1-2. PubMed ID: 24468044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations.
    Lencioni R; de Baere T; Burrel M; Caridi JG; Lammer J; Malagari K; Martin RC; O'Grady E; Real MI; Vogl TJ; Watkinson A; Geschwind JF
    Cardiovasc Intervent Radiol; 2012 Oct; 35(5):980-5. PubMed ID: 22009576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An In Vitro Evaluation of Four Types of Drug-Eluting Microspheres Loaded with Doxorubicin.
    de Baere T; Plotkin S; Yu R; Sutter A; Wu Y; Cruise GM
    J Vasc Interv Radiol; 2016 Sep; 27(9):1425-1431. PubMed ID: 27402527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma.
    Kang YJ; Lee BC; Kim JK; Yim NY; Kim HO; Cho SB; Jeong YY
    Cardiovasc Intervent Radiol; 2020 Jan; 43(1):55-64. PubMed ID: 31646378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
    Hoffmann R; Rempp H; Syha R; Ketelsen D; Pereira PL; Claussen CD; Clasen S
    Eur J Radiol; 2014 Oct; 83(10):1793-8. PubMed ID: 25052871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-Eluting Bead Transarterial Chemoembolization as Bridge Therapy for Hepatocellular Carcinoma Before Living-Donor Liver Transplantation.
    Yu CY; Ou HY; Weng CC; Huang TL; Chen TY; Leung-Chit L; Hsu HW; Chen CL; Cheng YF
    Transplant Proc; 2016 May; 48(4):1045-8. PubMed ID: 27320552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbubbles bound to drug-eluting beads enable ultrasound imaging and enhanced delivery of therapeutics.
    Owen J; Negussie AH; Burks SR; Delgado J; Mikhail AS; Rivera J; Pritchard WF; Karanian JW; Stride E; Frank JA; Wood BJ
    Sci Rep; 2024 Sep; 14(1):20929. PubMed ID: 39251665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
    Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
    Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idarubicin-loaded ONCOZENE drug-eluting embolic agents for chemoembolization of hepatocellular carcinoma: in vitro loading and release and in vivo pharmacokinetics.
    Guiu B; Schmitt A; Reinhardt S; Fohlen A; Pohl T; Wendremaire M; Denys A; Blümmel J; Boulin M
    J Vasc Interv Radiol; 2015 Feb; 26(2):262-70. PubMed ID: 25311967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.
    Brown KT; Do RK; Gonen M; Covey AM; Getrajdman GI; Sofocleous CT; Jarnagin WR; D'Angelica MI; Allen PJ; Erinjeri JP; Brody LA; O'Neill GP; Johnson KN; Garcia AR; Beattie C; Zhao B; Solomon SB; Schwartz LH; DeMatteo R; Abou-Alfa GK
    J Clin Oncol; 2016 Jun; 34(17):2046-53. PubMed ID: 26834067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New insights into the mechanisms of the interactions between doxorubicin and the ion-exchange hydrogel DC Bead™ for use in transarterial chemoembolization (TACE).
    Biondi M; Fusco S; Lewis AL; Netti PA
    J Biomater Sci Polym Ed; 2012; 23(1-4):333-54. PubMed ID: 21255482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and Safety of Transarterial Chemoembolization with DC Beads LUMI in the Treatment of HCC: Experience from a Tertiary Centre.
    Biondetti P; Lanza C; Carriero S; Arrigoni F; Bevilacqua M; Ruffino A; Triggiani S; Sorce A; Coppola A; Ierardi AM; Venturini M; Guzzardi G; Carrafiello G
    Technol Cancer Res Treat; 2023; 22():15330338231184840. PubMed ID: 37592839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer.
    Liu L; Liang X; Xu X; Zhang X; Wen J; Chen K; Su X; Teng Z; Lu G; Xu J
    Acta Biomater; 2021 Aug; 130():374-384. PubMed ID: 34082098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of irinotecan-loaded drug eluting beads (DC Bead) used for transarterial chemoembolization.
    Kaiser J; Thiesen J; Krämer I
    J Oncol Pharm Pract; 2010 Mar; 16(1):53-61. PubMed ID: 19617306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and Tolerability of Topotecan-Eluting Radiopaque Microspheres for Hepatic Chemoembolization in a Rabbit Preclinical Model.
    Mikhail AS; Levy EB; Krishnasamy VP; Woods DL; Esparza-Trujillo JA; Bakhutashvili I; Banovac F; Wakim PG; Negussie AH; Tang Y; Henman A; Willis SL; Karanian JW; Pritchard WF; Lewis AL; Wood BJ
    Cardiovasc Intervent Radiol; 2020 Dec; 43(12):1918-1924. PubMed ID: 32803282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison between drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis of six randomized controlled trials.
    Wang H; Cao C; Wei X; Shen K; Shu Y; Wan X; Sun J; Ren X; Dong Y; Liu Y; Zhai B
    J Cancer Res Ther; 2020; 16(2):243-249. PubMed ID: 32474508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.
    Xiang H; Long L; Yao Y; Fang Z; Zhang Z; Zhang Y
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819830751. PubMed ID: 30862264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Idarubicin
    Roth GS; Teyssier Y; Abousalihac M; Seigneurin A; Ghelfi J; Sengel C; Decaens T
    World J Gastroenterol; 2020 Jan; 26(3):324-334. PubMed ID: 31988592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review discussing the use of polyethylene glycol microspheres in the treatment of hepatocellular carcinoma.
    Fiorentini G; Sarti D; Carandina R; Mulazzani L; Mincarelli C; Candelari R; Argirò R; Fiorentini C; Aliberti C
    Future Oncol; 2019 Mar; 15(7):695-703. PubMed ID: 30444424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.
    Sadick M; Haas S; Loehr M; Elshwi M; Singer MV; Brade J; Schoenberg SO; Diehl SJ
    Onkologie; 2010; 33(1-2):31-7. PubMed ID: 20164659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.